NeuroFinance Human Stress Trial During Financial and Informational Volatility
NCT: NCT07622589 · ENROLLING_BY_INVITATION
Brief Summary
The NeuroFinance Human Stress Trial (NFHST-2026-001) is a decentralized observational clinical study designed to evaluate how financial market volatility, economic uncertainty, digital media exposure, and information-driven stress environments affect human physiologic and behavioral health. Participants will undergo remote monitoring using wearable biosensors, cardiovascular telemetry devices, sleep tracking systems, heart rate variability monitoring, and behavioral analytics platforms. The study will use artificial intelligence and machine learning systems to analyze relationships between external financial and informational events and biologic stress responses, including autonomic nervous system activity, sleep disruption, cardiovascular strain, emotional resilience, and inflammatory signaling. The goal of the study is to develop predictive digital biomarkers and AI-assisted forecasting systems capable of identifying stress-related physiologic deterioration before clinical manifestation.
Frequently Asked Questions
What is NeuroFinance Human Stress Trial During Financial and Informational Volatility?
NeuroFinance Human Stress Trial During Financial and Informational Volatility is a clinical trial registered under NCT07622589. Current status: ENROLLING_BY_INVITATION.
What is the status of NCT07622589?
The current status of NCT07622589 (NeuroFinance Human Stress Trial During Financial and Informational Volatility) is: ENROLLING_BY_INVITATION.
When did NeuroFinance Human Stress Trial During Financial and Informational Volatility start?
NeuroFinance Human Stress Trial During Financial and Informational Volatility started on 2026-07-15.
Official Source
View on ClinicalTrials.gov →Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.